Erythema Multiforme Global Clinical Trials Review, H2, 2017

2017-08-11
Price :
Published : Aug-2017
No. of Pages : 38
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Erythema Multiforme to Dermatology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Erythema Multiforme to Dermatology Clinical Trials 16
Clinical Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Erythema Multiforme Therapeutics Clinical Trials 24
Clinical Trial Profile Snapshots 26
Appendix 36
Abbreviations 36
Definitions 36
Research Methodology 37
Secondary Research 37
About GlobalData 38
Contact Us 38
Source 38

List of Tables
Erythema Multiforme Therapeutics, Global, Clinical Trials by Region, 2017* 7
Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
Erythema Multiforme Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase, 2017* 17
Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 21
Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25

List of Figures
Erythema Multiforme Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
Erythema Multiforme Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 21
Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
GlobalData Methodology 37
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData